Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Trillium Therapeutics Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 0 | Nov 17, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TRIL | Trillium Therapeutics Inc. | Nov 17, 2021 | 6 | $0 | 4 | Nov 19, 2021 | Chief Scientific Officer |
TRIL | Trillium Therapeutics Inc. | Jul 7, 2021 | 3 | -$31.7K | 4 | Jul 9, 2021 | Chief Scientific Officer |
TRIL | Trillium Therapeutics Inc. | Jun 7, 2021 | 3 | -$29K | 4 | Jun 9, 2021 | Chief Scientific Officer |
TRIL | Trillium Therapeutics Inc. | May 7, 2021 | 3 | -$32.8K | 4 | May 11, 2021 | Chief Scientific Officer |